Loading...
Miglustat Treatment May Reduce Cerebrospinal Fluid Levels of the Axonal Degeneration Marker Tau in Niemann–Pick Type C
Introduction: Niemann–Pick disease type C (NPC) is a lysosomal storage disorder that leads to progressive neurodegeneration. The glucosylceramide synthase blocker miglustat is being used to treat NPC, but monitoring of disease progression and treatment response is difficult. NPC patients have elevat...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3509856/ https://ncbi.nlm.nih.gov/pubmed/23430872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_47 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|